Welcome to our dedicated page for ISPIRE TECHNOLOGY news (Ticker: ISPR), a resource for investors and traders seeking the latest updates and insights on ISPIRE TECHNOLOGY stock.
Ispire Technology Inc. (NASDAQ: ISPR) generates a steady flow of news centered on vaping technology, precision dosing and regulatory engagement across nicotine and cannabis markets. As a tobacco manufacturing company focused on e‑cigarettes and cannabis vaping hardware, its announcements often highlight product launches, manufacturing milestones and developments in age‑verification technology.
Company news frequently covers the evolution of its Aspire and Ispire product lines, including detailed hardware ecosystems for cannabis brands and structured device architectures unveiled at major industry events such as MJBizCon. These updates describe new series of devices designed for different formulations, performance requirements and use cases, reflecting Ispire’s emphasis on hardware engineering and ODM partnerships.
Ispire’s press releases also address regulatory and compliance themes. The company and its joint venture IKE Tech LLC report on progress with FDA submissions, including a component Pre‑Market Tobacco Product Application (PMTA) for a blockchain‑enabled age‑verification chip, as well as responses to policy actions targeting illicit vape markets and youth access. Additional coverage includes conference participation in nicotine delivery and cannabis capital events, where company executives discuss harm reduction, identity verification and market trends within regulated ENDS and cannabis hardware sectors.
Operational updates, such as the interim nicotine manufacturing license in Malaysia and statements from Ispire Malaysia about export‑only manufacturing and regulatory compliance, provide further context on the company’s manufacturing footprint and strategic initiatives. Investors, analysts and industry participants can use this news feed to follow Ispire’s product roadmap, regulatory interactions, manufacturing expansion and joint‑venture activities. Bookmark this page to monitor ongoing announcements, event participation and technology disclosures related to ISPR.
Ispire Technology (NASDAQ: ISPR) joint venture IKE Tech engaged the FDA Center for Tobacco Products on April 9, 2026 to present point-of-use compliance technologies for ENDS, including its patented Human Identity Token (HIT), biometric age-gating, blockchain product authentication, and AI governance.
IKE Tech said its standalone component PMTA for interoperable age-gating was accepted by FDA in June 2025 and a Human Factors Validation Study showed 100% prevention of underage device activation.
IKE Tech (NYSE:ISPR) welcomed the FDA's March 2026 draft guidance that, for the first time, explicitly recognizes continuous, device-level age verification (Device Access Restrictions) as a factor in PMTA APPH determinations.
IKE Tech highlights its April 2025 component PMTA, a validated BLE/biometric/blockchain age-gating system with a multi-center human factors study showing 100% successful verification (n=101) and 0% underage activation.
Ispire (NASDAQ: ISPR) says FDA draft guidance on flavored ENDS recognizes device-level age verification and may unlock a $50 billion U.S. total addressable market by enabling lawful transition of primarily illicit flavored vape sales into a compliant ecosystem. Ispire's 40% JV, IKE Tech, claims $5M–$20M annual SaaS revenue per customer and says it filed the first component PMTA for continuous, blockchain-enabled age-gating technology with human-factors results cited as 100% underage prevention and 100% demographic accuracy.
Ispire Technology (NASDAQ: ISPR) will participate in the 38th Annual ROTH Conference in Dana Point, California from March 22-24, 2026. Management will host a fireside chat on March 23, 2026 at 8:00 a.m. PT in Blue-Consumer-Salon 2.
Investors may request one-on-one meetings by contacting a ROTH representative or emailing Ispire@KCSA.com.
Ispire Technology (NASDAQ: ISPR) reported fiscal Q2 2026 results for the quarter ended December 31, 2025, showing revenue of $20.3M (versus $41.8M prior year) and a net loss of $6.6M ($0.12 per share). Cash totaled $17.6M and working capital was $3.5M.
The company said gross profit was $3.5M (17.1% margin) and operating expenses declined to $10.3M as AR fell 19.5% to $37.9M, reflecting a shift to higher-quality customers and cost controls.
Ispire (NASDAQ: ISPR) said IKE Tech, a joint venture with Ispire as a founding partner, was invited to an FDA Roundtable on PMTA submissions on February 10, 2026. The invitation, limited to 30 companies, recognizes IKE Tech as a stakeholder and the role of point-of-use age-gating technology. IKE will join the Manufacturing Controls panel and has submitted the first-ever component PMTA for an interoperable, blockchain-enabled Bluetooth age-verification system.
The company framed the engagement as a chance to inform PMTA guidance and advance regulatory-ready, youth-protective technical controls for ENDS products.
WM Technology (Nasdaq: MAPS) appointed Harry DeMott and Brent Cox to its Board of Directors effective February 1, 2026, and confirmed Susan Echard will transition from a contracted CFO role to full employment effective January 30, 2026. The additions emphasize cannabis industry, technology, and capital markets experience.
The company said the new directors bring board and operating experience to support Weedmaps marketplace and the firm's growth in the evolving cannabis sector.
Ispire Technology (NASDAQ: ISPR) will hold its fiscal second quarter 2026 earnings conference call at 8:00 am ET on Friday, February 6, 2026 to discuss results for the quarter ended December 31, 2025. The call is available by dial-in or live webcast.
Dial-in numbers include US 877-451-6152 and International +1 201-389-0879. The webcast link is provided for registration; attendees should access it at least fifteen minutes early. A playback replay will be available through 11:59 pm ET on February 20, 2026 with passcode 13758138.
Credit Acceptance (Nasdaq: CACC) announced an amendment extending its $100.0 million asset-backed non-recourse secured financing (Term ABS 2021-1). The financing's revolve stop date was extended from February 17, 2026 to January 18, 2028. The borrowing spread was reduced from SOFR + 220 bps to SOFR + 140 bps, with no other material term changes.
The company reiterated its business description and provided investor contact details.
Ispire Technology (NASDAQ: ISPR) will unveil a fully reengineered cannabis hardware ecosystem at MJBizCon 2025, Dec 2–5 at the Las Vegas Convention Center. The launch introduces three product families—E-Series (Essentials), S-Series (Specialized) and C-Series (Custom/ODM)—with devices designed for varied oil viscosities, activation types (draw/button/dual) and global compliance. Key models include compact draw-activated and high-viscosity units, flagship dual-activation devices, and fully custom ODM options. Senior executives, including VP of Sales John Monds, will be available for on-site meetings; scheduling via john.monds@getispire.com.